Current Liabilities

Total Current Liabilities

Kailera Therapeutics Total Current Liabilities increased by 18.2% to $54.84M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

An increase suggests rising short-term obligations, which may strain liquidity if not matched by current asset growth.

Detailed definition

This is the aggregate sum of all financial obligations that the company is required to settle within one year or the cur...

Peer comparison

Universal metric for assessing short-term solvency across all industries.

Metric ID: total_current_liabilities

Historical Data

2 periods
 Q4 '25Q1 '26
Value$46.41M$54.84M
QoQ Change+18.2%
Range$46.41M$54.84M

Frequently Asked Questions

What is Kailera Therapeutics 's total current liabilities?
Kailera Therapeutics (KLRA) reported total current liabilities of $54.84M in Q1 2026.
What does total current liabilities mean?
The total amount of all debts and obligations due within the next twelve months.